Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Caroline Igo (she/her/hers) is a wellness editor and holds Sleep Science Coach and Stress Management certificates from the Spencer Institute. She received her bachelor's degree in creative writing ...
The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.
The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.
Here, five nutrition experts review seven foods and drinks to limit or avoid when taking Ozempic and why reducing them may ...
Wondr Plus delivers improved metabolic health outcomes and meaningful ROI for employers ready to tackle workforce obesity ...
Newsweek and Statista are partnering for the first time to name America's Best Weight Loss Clinics & Centers 2025, recognizing 200 facilities nationwide that help people make healthy lifestyle changes ...
When it comes to weight loss journeys, we often focus on before-and-after photos and diet tips. But what happens when your ...
Jefferson Health, the region’s largest provider of primary care, is rolling out a new research-based tool to offer patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback